Neuromity is pioneering treatments for neurological disorders using deuterium-enabled chiral switching (DECS). Our lead program, NTY-184 (deuterium-stabilized S-bupropion), is being developed initially for major depressive disorder (MDD) as an NCE with new composition of matter IP via an expedited a...
Use this information to figure out if this company is an ideal customer for you.
857.453.6773
800 Boylston Street
Boston, 02199
11 - 50 Employees
$1M - $5M
linkedin.com/company/neuromity
Neuromity Therapeutics Inc.'s HQ is located at 800 Boylston Street, Boston
Neuromity Therapeutics Inc.'s phone number is 857.453.6773
Neuromity Therapeutics Inc.'s official website is neuromity.com
Neuromity Therapeutics Inc.'s revenue is $1M - $5M
Neuromity Therapeutics Inc. has 11 - 50 employees
Neuromity Therapeutics Inc. is in the industry of: Pharmaceuticals
